Evidence-Based Nutrition for Heart Health & Longevity
The most evidence-dense intersection of nutrition and longevity. Covers coronary artery disease, LDL/ApoB, hypertension, heart failure support, triglycerides, and stroke prevention — with guideline-level citations and explicit medication cautions.
1 — Best-supported dietary patterns
The most extensively studied dietary pattern for cardiovascular outcomes. The PREDIMED trial (Estruch 2013, NEJM) showed 30% reduction in major cardiovascular events vs low-fat diet in high-risk adults — extra-virgin olive oil and nuts were the key additions.
- Olive oil as primary fat
- Legumes, vegetables, fruits daily
- Fatty fish 2–3×/week
- Nuts daily (30g)
- Moderate red wine optional, not required
Designed specifically for hypertension but also improves lipid markers. Reduces systolic BP 8–14 mmHg in RCTs (Appel 1997, NEJM). Complementary to Mediterranean — combining both (MedDASH) may be additive.
- 8–10 fruits and vegetables/day
- Low-fat dairy 2–3 servings/day
- Sodium <2,300mg/day
- Whole grains, lean protein, nuts
Combines four evidence-based LDL-lowering foods to achieve statin-comparable LDL reduction without medication. Reduces LDL-C 28–35% in RCTs (Jenkins 2003, JAMA).
- Plant protein (soy, legumes) 50g/day
- Viscous fiber (oat, barley) 20g/day
- Plant sterols 2g/day
- Nuts 30–45g/day
Not necessarily vegan — plant-predominant with animal foods as condiment rather than centerpiece. Associated with lowest atherosclerosis progression rates in observational data. Ornish Lifestyle Medicine showed regression of coronary artery disease in RCT.
- Vegetables and legumes as dietary base
- Minimal refined carbohydrates
- Fatty fish and eggs acceptable
- Minimal processed meat
2 — Condition-specific nutrition targets
Mediterranean diet with extra-virgin olive oil. Target ApoB <80 mg/dL (statin + diet). Prioritize fiber 35g/day. Eliminate trans fats. Reduce saturated fat below 10% of calories. Consider Portfolio approach for maximal LDL-C reduction without medication.
The most nutrition-responsive of all lipid markers. Eliminate all sugar-sweetened beverages and refined carbohydrates — these are the primary drivers. Alcohol markedly worsens hypertriglyceridemia. EPA+DHA omega-3 at 2–4g/day reduces triglycerides 15–30% (REDUCE-IT used 4g icosapent ethyl). Weight loss 5–10% reduces triglycerides 20–30%.
Sodium restriction 1.5–2g/day remains guideline-recommended for symptomatic HF. Fluid management if indicated. CoQ10 300mg/day showed 43% reduction in major cardiac events in Q-SYMBIO trial in HFrEF. Thiamine monitoring important (loop diuretics deplete thiamine). High-quality protein and resistance training to prevent cardiac cachexia.
Mediterranean diet associated with lower AF incidence in observational data. Omega-3 evidence is paradoxical — REDUCE-IT (high-dose EPA) showed increased AF risk 3% vs 2.1%, while standard fish oil doses appear neutral to protective. Magnesium deficiency associated with AF risk; magnesium supplementation sometimes used peri-operatively. Alcohol is the most modifiable dietary AF trigger — "holiday heart" is real.
Blood pressure control is the single most important modifiable stroke risk factor — DASH diet, sodium restriction, potassium. Mediterranean diet reduced stroke risk ~29% in PREDIMED. For ischemic stroke: anti-inflammatory diet, omega-3, fiber. For hemorrhagic stroke: blood pressure control paramount; avoid high-dose fish oil (>3g/day) if on anticoagulation.
2023 AHA/ACC guideline: healthy dietary habits as nonpharmacologic therapy for all chronic coronary disease. Mediterranean pattern remains the best-evidenced post-procedure diet. Omega-3 should be coordinated with anticoagulation/antiplatelet therapy (aspirin + clopidogrel). Statin continuation is medication — dietary changes do not substitute. CoQ10 may reduce statin myopathy symptoms.
3 — Foods with the strongest cardiovascular evidence
4 — Foods to limit
- Processed and red meat — deli meats, hot dogs, bacon: associated with higher CV mortality in cohort studies; saturated fat + sodium + nitrates
- Sugar-sweetened beverages — sodas, fruit juice, energy drinks: raise triglycerides, promote insulin resistance and visceral fat
- Trans fats — still present in some fried foods and partially hydrogenated oils: raise LDL-C and lower HDL-C; dose-dependently increase CV risk
- Refined carbohydrates — white bread, white rice, breakfast cereals: raise triglycerides, promote insulin resistance, displace fiber-rich foods
- Excess sodium — >2,300mg/day: raises blood pressure; most comes from processed and restaurant food, not the salt shaker
- Alcohol in excess — >1 drink/day (women), >2 (men): raises blood pressure, worsens hypertriglyceridemia, triggers AF; "J-curve" benefit claim is contested
- Coconut oil — raises LDL-C reliably despite marketing claims; no cardiovascular outcome data supporting use
- Ultra-processed foods (NOVA Class 4) — independently associated with higher CV mortality beyond nutrient composition in cohort studies
5 — Supplements: evidence vs overhyped
- Red yeast rice: contains monacolin K (identical to lovastatin) — carries all statin risks without pharmaceutical quality control or dose certainty. Consult physician before use.
- Niacin on top of statins: AIM-HIGH and HPS2-THRIVE showed no additional CV benefit vs statin alone; raises HDL but doesn't improve outcomes.
- High-dose Vitamin E: HOPE trial showed no CV benefit; meta-analysis found possible harm at >400 IU/day in high-risk patients.
- Beta-carotene supplements: increased lung cancer risk in smokers (CARET trial); no CV benefit demonstrated.
- OTC fish oil as prescription equivalent: prescription icosapent ethyl (Vascepa) is pure EPA at 4g/day — not equivalent to OTC mixed EPA+DHA at 1g/day. Triglyceride reduction yes; MACE reduction data belongs to the prescription formulation.
6 — Labs to track
- ApoB — primary target (<80 mg/dL if high risk)
- LDL-C (treat to guideline)
- Non-HDL-C
- Triglycerides (<150 mg/dL)
- Lp(a) — genetic, order once
- LDL-P (particle number, if available)
- hs-CRP (<1.0 mg/L optimal)
- Fasting insulin / HOMA-IR
- HbA1c
- Fasting glucose
- eGFR (renal function)
- Homocysteine (B12/folate marker)
- Blood pressure (home monitor)
- CAC score (coronary artery calcium) — once if intermediate risk
- Ankle-brachial index
- Resting + exercise ECG
- Echocardiogram if indicated
⚠ Medication & Nutrient Cautions — Cardiac Patients
- Omega-3 + anticoagulants / antiplatelets: ≥3g/day increases bleeding risk. Patients on warfarin, aspirin, clopidogrel (Plavix), or apixaban (Eliquis) should coordinate omega-3 dose with prescriber before exceeding OTC doses. INR monitoring recommended.
- Red yeast rice + statins: additive myopathy and rhabdomyolysis risk. Do not combine without explicit physician guidance. Red yeast rice is essentially an unregulated statin.
- Vitamin K2 + warfarin: K2 (menaquinone) directly antagonizes warfarin. Cannot take K2 without physician coordination and INR monitoring.
- CoQ10 + warfarin: may have modest anticoagulant effect. Monitor INR if starting CoQ10 on warfarin.
- Grapefruit + statins: grapefruit inhibits CYP3A4 — can dramatically increase statin blood levels, raising myopathy risk. Avoid grapefruit entirely on simvastatin or atorvastatin.
- Loop diuretics (furosemide) deplete: potassium, magnesium, thiamine (B1), zinc. Monitor and supplement under physician guidance — especially thiamine in heart failure.
- ACE inhibitors / ARBs + potassium supplements: hyperkalemia risk. Do not add potassium supplements without checking serum potassium levels.
- Fish oil ≥4g/day increases AF risk: REDUCE-IT and STRENGTH trials both showed modestly increased atrial fibrillation events at high prescription doses. Discuss with cardiologist if you have AF history.
Full contraindications tool → · Drug-nutrient depletion checker → · Full CV supplement rankings →
8 — When to consult your physician or cardiologist
- ApoB ≥100 mg/dL with any cardiovascular risk factor — medication conversation warranted
- LDL-C ≥190 mg/dL — guidelines recommend statin therapy
- Lp(a) ≥75 nmol/L — diet does not lower Lp(a); specialist conversation required
- Blood pressure ≥160/100 mmHg — medication typically indicated
- Any diagnosed heart failure — nutrition changes should be supervised
- Post-MI, post-stent, or post-CABG — cardiac rehabilitation plus physician-supervised nutrition protocol
- Before starting omega-3 >2g/day if on anticoagulation
- Before starting red yeast rice — it carries statin-class risks
- If experiencing chest pain, shortness of breath, palpitations, or unexplained fatigue — these are symptoms first, a nutrition conversation second